Potential Uses of Corticotropin‐Releasing Hormone Antagonists
E Zoumakis, KC Rice, PW Gold… - Annals of the New York …, 2006 - Wiley Online Library
E Zoumakis, KC Rice, PW Gold, GP Chrousos
Annals of the New York Academy of Sciences, 2006•Wiley Online LibraryCorticotropin‐releasing hormone (CRH), its natural homologs urocortins (UCN) 1, 2, and 3,
and several types of CRH receptors (R), coordinate the behavioral, endocrine, autonomic,
and immune responses to stress. The potential use of CRH antagonists is currently under
intense investigation. Selective antagonists have been used experimentally to clarify the role
of CRH‐related peptides in anxiety and depression, addictive behavior, inflammatory
disorders, acute and chronic neurodegeneration, and sleep disorders, as well as preterm …
and several types of CRH receptors (R), coordinate the behavioral, endocrine, autonomic,
and immune responses to stress. The potential use of CRH antagonists is currently under
intense investigation. Selective antagonists have been used experimentally to clarify the role
of CRH‐related peptides in anxiety and depression, addictive behavior, inflammatory
disorders, acute and chronic neurodegeneration, and sleep disorders, as well as preterm …
Abstract
Corticotropin‐releasing hormone (CRH), its natural homologs urocortins (UCN) 1, 2, and 3, and several types of CRH receptors (R), coordinate the behavioral, endocrine, autonomic, and immune responses to stress. The potential use of CRH antagonists is currently under intense investigation. Selective antagonists have been used experimentally to clarify the role of CRH‐related peptides in anxiety and depression, addictive behavior, inflammatory disorders, acute and chronic neurodegeneration, and sleep disorders, as well as preterm labor.
Wiley Online Library